{"id":"W4413372506","doi":"10.1016/j.ijgc.2025.102117","title":"Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Instituto de Salud Carlos III; Eisai; Seagen; Gilead Sciences; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Medicine; Antibody-drug conjugate; Gynecologic cancer; Drug; Antibody; Gynecology; Oncology; Pharmacology; Monoclonal antibody; Internal medicine; Ovarian cancer; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001680359,0.0007089184,0.003384179,0.00154568,0.0001540854,0.001154251,0.00102648,0.001357721,0.00440024],"category_scores_gemma":[0.003502698,0.0003030615,0.002271013,0.001553817,0.0003661486,0.0008657062,0.0004970571,0.001222544,0.0005557887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005468214,"about_ca_system_score_gemma":0.001298521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001317349,"about_ca_topic_score_gemma":0.002635315,"domain_scores_codex":[0.9993755,0.0001740973,0.000151682,0.00008269104,0.0001835279,0.00003251404],"domain_scores_gemma":[0.9977503,0.001618398,0.0004038943,0.00002533006,0.0001662076,0.00003589801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006738021,0.00009137697,0.0005543592,0.1369066,0.001825733,0.0001268317,0.0000421342,0.0005419364,0.00102233,0.001162694,0.00723813,0.8498141],"study_design_scores_gemma":[0.001193283,0.002206585,0.009516618,0.1579195,0.02415832,0.002850911,0.0003330304,0.0007589365,0.002579839,0.004922254,0.7934292,0.0001314762],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001252694,0.9995779,0.00003925648,0.00007464091,0.00002817033,0.000004609318,0.00002026034,0.00000169041,0.0001280885],"genre_scores_gemma":[0.001647669,0.9979335,0.0001270739,0.0001329721,0.00004509575,0.000006292347,0.00002644926,6.537707e-7,0.00008028145],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00440024,"threshold_uncertainty_score":0.01472032,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2198632106369881,"score_gpt":0.5025747878709089,"score_spread":0.2827115772339208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}